Recall Register

Food, drugs, devices › Lab Vision Corporation

Device recall: CEA / CD66e Ab-2, Product code RB-368-R7, RB-368-R1; 7 ml each. Description  Carcinoembryonic antigen (CEA), is synthes

FDA enforcement event 73120 · Class III · initiated 18 Jan 2016 · status Terminated · terminated 24 Jun 2016

DeviceVoluntary: Firm initiated1 product recordFremont, CA

Lab Vision Corporation (Fremont, CA) initiated this device recall on 18 Jan 2016; FDA lists 1 product record under event 73120, classified Class III.

FDA defines Class III as a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences. 5% of the 1,232 device enforcement events initiated in 2016 carry the same class.

Status: Terminated, terminated 24 Jun 2016. Initiation: voluntary: firm initiated. Lab Vision Corporation has 3 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Lab Vision Corporation, Fremont, CA.

Reason for recall

"Certain lots of CEA/CD66e Ab2 were produced with a dilution factor of 1:100 instead of the recommended 1:250."

Distribution

"Worldwide Distribution - US including CA, NY, GA, MS, PA, MA, TX, KY, AZ. and Internationally to Greece, France, Germany, Singapore and Serbia."

Product records

Recall numberProductQuantityClassStatusReport date
Z-0815-2016CEA / CD66e Ab-2, Product code RB-368-R7, RB-368-R1; 7 ml each. Description  Carcinoembryonic antigen (CEA), is synthesized during development in the fetal gut, and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Antibody to CEA is reportedly useful in identifying the origin…RB-368-R7 - 30; RB-368-R1 -2Class IIITerminated24 Feb 2016

Context

5%of 2016 device events are Class III1,232 events that year
1product record in this eventfirm median: 1
3events on this register for the firm

Other enforcement events for Lab Vision Corporation

InitiatedProduct (first record)TypeClassRecords
27 Oct 2015Thermo Scientific p21 WF1 Ab-3 (DCS-60.2) 1 ml (0.4mg/ml): Product code: MS-230-P and MS-230P0; Hematology: p21WAF1/Cip1DeviceClass III1
6 Dec 2013Estrogen Receptor AB-11 (Clone ID5) Mouse Monoclonal Antibody 1 mk (2mg.ml) Manufactured by: Lab Vision Corporation, FreDeviceClass II1

All 3 events for Lab Vision Corporation

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Certain lots of CEA/CD66e Ab2 were produced with a dilution factor of 1:100 instead of the recommended 1:250."

What does Class III mean?

FDA classifies recalls by relative degree of health hazard. Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide Distribution - US including CA, NY, GA, MS, PA, MA, TX, KY, AZ. and Internationally to Greece, France, Germany, Singapore and Serbia."

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 24 Jun 2016. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.